DRI Healthcare Trust Units DHT.U
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DHT.U is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $10.83
- Day Range
- $11.00–11.00
- 52-Week Range
- $7.51–12.81
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $619.94 Mil
- Volume/Avg
- 2,500 / 3,650
Key Statistics
- Price/Earnings (Normalized)
- 21.39
- Price/Sales
- 1.96
- Dividend Yield (Trailing)
- 2.82%
- Dividend Yield (Forward)
- 3.09%
- Total Yield
- 2.82%
Company Profile
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 35
- Website
- https://www.dricapital.com
Comparables
Valuation
|
Metric
|
DHT.U
|
HCW
|
NXR.UN
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.39 | 18.48 | 12.28 |
Price/Book Value | 1.12 | 0.69 | 0.46 |
Price/Sales | 1.96 | 9.03 | 2.94 |
Price/Cash Flow | 5.81 | 29.16 | 10.14 |
Price/Earnings
DHT.U
HCW
NXR.UN
Financial Strength
|
Metric
|
DHT.U
|
HCW
|
NXR.UN
|
|---|---|---|---|
Quick Ratio | — | 0.46 | 0.04 |
Current Ratio | — | 1.15 | 0.46 |
Interest Coverage | — | 1.48 | 5.28 |
Quick Ratio
DHT.U
HCW
NXR.UN
Profitability
|
Metric
|
DHT.U
|
HCW
|
NXR.UN
|
|---|---|---|---|
Return on Assets (Normalized) | 11.01% | 1.10% | 8.64% |
Return on Equity (Normalized) | 17.71% | 1.74% | 20.83% |
Return on Invested Capital (Normalized) | — | 2.83% | 11.08% |
Return on Assets
DHT.U
HCW
NXR.UN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Mjykzrbyh | Rkfpxz | $80.3 Bil | |||
| Zoetis Inc Class A
ZTS
| Zxhhqfkkm | Bkjq | $77.8 Bil | |||
| Haleon PLC ADR
HLN
| Hxtqjdxl | Ldjpc | $37.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fdcjhpgb | Czqq | $12.1 Bil | |||
| Viatris Inc
VTRS
| Tpmbhyzx | Jbkw | $12.1 Bil | |||
| Catalent Inc
CTLT
| Tqwfsfwk | Sbyfxpg | $10.0 Bil | |||
| Perrigo Co PLC
PRGO
| Whyhvbgl | Zgy | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Trkyttlsy | Rqpfk | $3.2 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Brhtwggpl | Cxdr | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Nvsjdjbsz | Prfq | $2.7 Bil |